OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports
Thawatchai Khuanjing, Siripong Palee, Siriporn C. Chattipakorn, et al.
Acta Physiologica (2019) Vol. 228, Iss. 2
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction
Bahira Shahim, Hong Xu, Kristina H. Haugaa, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 2, pp. 128-136
Open Access | Times Cited: 8

Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis
Thawatchai Khuanjing, Benjamin Ongnok, Chayodom Maneechote, et al.
Pharmacological Research (2021) Vol. 173, pp. 105882-105882
Closed Access | Times Cited: 46

High-precision colorimetric-fluorescent dual-mode biosensor for detecting acetylcholinesterase based on a trimetallic nanozyme for efficient peroxidase-mimicking
Meie Zheng, Mingxing Liu, Zichen Song, et al.
Journal of Material Science and Technology (2024) Vol. 191, pp. 168-180
Closed Access | Times Cited: 7

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42

Macrophages: First guards in the prevention of cardiovascular diseases
Moussa Ide Nasser, Shuoji Zhu, Huanlei Huang, et al.
Life Sciences (2020) Vol. 250, pp. 117559-117559
Open Access | Times Cited: 37

Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats
Veronica F. Salau, Ochuko L. Erukaınure, Kolawole A. Olofinsan, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 1, pp. 44-59
Open Access | Times Cited: 19

Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats
Michal Bencze, Almos Boroš, Michal Behuliak, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176526-176526
Open Access | Times Cited: 4

Cholinesterase inhibitors and reduced risk of hospitalization and mortality in patients with Alzheimer's dementia and heart failure
Marianne Reimers-Wessberg, Hong Xu, Johan Fastbom, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2025)
Closed Access

Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue
Basil S. Lewis
European Heart Journal - Cardiovascular Pharmacotherapy (2025)
Closed Access

Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Thawatchai Khuanjing, Chayodom Maneechote, Benjamin Ongnok, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9

Treating heart failure by targeting the vagus nerve
Francesco Gentile, Giulia Orlando, Sabrina Montuoro, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 6, pp. 1201-1215
Open Access | Times Cited: 3

Neuroimmune cross-talk in heart failure
Sabrina Montuoro, Francesco Gentile, Alberto Giannoni
Cardiovascular Research (2024)
Closed Access | Times Cited: 3

Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systematic review and meta-analysis
Hecheng Wang, Yu Zong, Yanshuo Han, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 3, pp. 407-415
Closed Access | Times Cited: 15

Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study
Ming‐Jer Hsieh, Dong‐Yi Chen, Cheng‐Hung Lee, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13

Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction
Thawatchai Khuanjing, Chayodom Maneechote, Benjamin Ongnok, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115836-115836
Closed Access | Times Cited: 7

Mitochondrial homeostasis and redox status in cardiovascular diseases: Protective role of the vagal system
Xijing He, Jiankang Liu, Weijin Zang
Free Radical Biology and Medicine (2021) Vol. 178, pp. 369-379
Closed Access | Times Cited: 16

The role of extracellular vesicles in pyroptosis-mediated infectious and non-infectious diseases
Cai‐Hua Zhang, Ding-Ci Lu, Ying Liu, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112633-112633
Closed Access | Times Cited: 2

Ecliptasaponin A protects heart against acute ischemia-induced myocardial injury by inhibition of the HMGB1/TLR4/NF-κB pathway
Sumin Ge, Sihua Wu, Qin Yin, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118612-118612
Closed Access | Times Cited: 2

Protective Role of Acetylcholine and the Cholinergic System in the Injured Heart
Clara Liu Chung Ming, Xiaowei Wang, Carmine Gentile
iScience (2024) Vol. 27, Iss. 9, pp. 110726-110726
Open Access | Times Cited: 2

Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure
Gisele Lopes Cavalcante, Fernanda Brognara, Lucas Vaz de Castro Oliveira, et al.
Acta Physiologica (2021) Vol. 232, Iss. 3
Closed Access | Times Cited: 15

Intracerebroventricular infusion of donepezil prevents cardiac remodeling and improves the prognosis of chronic heart failure rats
Meihua Li, Can Zheng, Toru Kawada, et al.
The Journal of Physiological Sciences (2020) Vol. 70, Iss. 1
Open Access | Times Cited: 14

Impact of Peripheral α7-Nicotinic Acetylcholine Receptors on Cardioprotective Effects of Donepezil in Chronic Heart Failure Rats
Meihua Li, Can Zheng, Toru Kawada, et al.
Cardiovascular Drugs and Therapy (2020) Vol. 35, Iss. 5, pp. 877-888
Closed Access | Times Cited: 14

Page 1 - Next Page

Scroll to top